Psychotherapy-supported MDMA treatment for PTSD
Open Access
- 17 August 2021
- journal article
- editorial
- Published by Elsevier BV in Cell Reports Medicine
- Vol. 2 (8), 100378
- https://doi.org/10.1016/j.xcrm.2021.100378
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyNature Medicine, 2021
- Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)Brain Research, 2020
- Effects of MDMA on attention to positive social cues and pleasantness of affective touchNeuropsychopharmacology, 2019
- 3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in ratsPhysiology & Behavior, 2018
- Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of EcstasyMindfulness, 2017
- Separating the agony from ecstasy: R(–)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in miceNeuropharmacology, 2017
- Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)Psychopharmacology, 2017
- The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?Journal of Psychopharmacology, 2016
- The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memoriesInternational Journal of Neuropsychopharmacology, 2013